• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运动障碍中认知障碍的筛查:帕金森病和路易体痴呆中蒙特利尔认知评估与快速轻度认知障碍筛查的比较

Screening for Cognitive Impairment in Movement Disorders: Comparison of the Montreal Cognitive Assessment and Quick Mild Cognitive Impairment Screen in Parkinson's Disease and Lewy Body Dementia.

作者信息

O'Caoimh Rónán, Foley Mary J, Timmons Suzanne, Molloy D William

机构信息

Department of Geriatric and Stroke Medicine, Mercy University Hospital, Grenville Place, Cork, Ireland.

Health Research Board Clinical Research Facility, University College Cork, Mercy University Hospital, Cork, Ireland.

出版信息

J Alzheimers Dis Rep. 2024 Jun 21;8(1):971-980. doi: 10.3233/ADR-230207. eCollection 2024.

DOI:10.3233/ADR-230207
PMID:39114555
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11305847/
Abstract

BACKGROUND

The Montreal Cognitive Assessment (MoCA) is recommended by the Movement Disorder Society for cognitive testing in movement disorders including Parkinson's disease (PD) and lewy body dementia. Few studies have compared cognitive screening instruments in these diseases, which overlap clinically.

OBJECTIVE

To compare the MoCA and Quick Mild Cognitive Impairment (Q screen in this population.

METHODS

Patients attending memory and movement disorder clinics associated with a university hospital had the MoCA and Q screen performed and diagnostic accuracy compared with the area under the receiver operating characteristic curve (AUC). Duration and severity of movement disorders was assessed using the Unified PD Rating Scale (UPDRS).

RESULTS

In total, 133 assessments were available, median age 74±5. Median education was 11±4 years and 65% were male. Median total UPDRS score was 37±26. Median Q screen was 51±27, median MoCA was 19±10. There were statistically significant differences in test scores between those with subjective symptoms but normal cognition, mild cognitive impairment (MCI) and dementia ( < 0.001). The Q screen had significantly greater accuracy differentiating normal cognition from MCI versus the MoCA (AUC 0.90 versus 0.72,  = 0.01). Both instruments had similar accuracy in identifying cognitive impairment and separating MCI from dementia. The median administration time for the Q screen and MoCA were 5.19 and 9.24 minutes ( < 0.001), respectively.

CONCLUSIONS

Both the MoCA and Q screen have good to excellent accuracy in a population with movement disorders experiencing cognitive symptoms. The Q screen was significantly more accurate for those with early symptoms and had a shorter administration time.

摘要

背景

蒙特利尔认知评估量表(MoCA)被运动障碍协会推荐用于帕金森病(PD)和路易体痴呆等运动障碍的认知测试。很少有研究比较这些临床症状重叠的疾病中的认知筛查工具。

目的

比较MoCA和简易精神状态检查表(Q)在该人群中的表现。

方法

在大学医院的记忆和运动障碍门诊就诊的患者接受了MoCA和Q测试,并将诊断准确性与受试者工作特征曲线(AUC)下的面积进行比较。使用统一帕金森病评定量表(UPDRS)评估运动障碍的持续时间和严重程度。

结果

总共进行了133次评估,中位年龄为74±5岁。中位受教育年限为11±4年,65%为男性。UPDRS总分中位数为37±26。Q测试中位数为51±27,MoCA中位数为19±10。主观症状正常、轻度认知障碍(MCI)和痴呆患者的测试分数存在统计学显著差异(<0.001)。与MoCA相比,Q测试在区分正常认知与MCI方面具有显著更高的准确性(AUC分别为0.90和0.72,P=0.01)。两种工具在识别认知障碍和区分MCI与痴呆方面具有相似的准确性。Q测试和MoCA的中位施测时间分别为5.19分钟和9.24分钟(P<0.001)。

结论

MoCA和Q测试在有认知症状的运动障碍人群中均具有良好到优异的准确性。Q测试对早期症状患者的准确性显著更高,且施测时间更短。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0644/11305847/71bb0268bc0f/adr-8-adr230207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0644/11305847/71bb0268bc0f/adr-8-adr230207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0644/11305847/71bb0268bc0f/adr-8-adr230207-g001.jpg

相似文献

1
Screening for Cognitive Impairment in Movement Disorders: Comparison of the Montreal Cognitive Assessment and Quick Mild Cognitive Impairment Screen in Parkinson's Disease and Lewy Body Dementia.运动障碍中认知障碍的筛查:帕金森病和路易体痴呆中蒙特利尔认知评估与快速轻度认知障碍筛查的比较
J Alzheimers Dis Rep. 2024 Jun 21;8(1):971-980. doi: 10.3233/ADR-230207. eCollection 2024.
2
Comparison of the Quick Mild Cognitive Impairment (Qmci) screen to the Montreal Cognitive Assessment (MoCA) in an Australian geriatrics clinic.在澳大利亚老年病诊所中,快速轻度认知障碍(Qmci)筛查与蒙特利尔认知评估(MoCA)的比较。
Int J Geriatr Psychiatry. 2017 Jun;32(6):643-649. doi: 10.1002/gps.4505. Epub 2016 Jul 18.
3
Screening for Mild Cognitive Impairment: Comparison of "MCI Specific" Screening Instruments.轻度认知障碍的筛查:“MCI 特异性”筛查工具的比较
J Alzheimers Dis. 2016;51(2):619-29. doi: 10.3233/JAD-150881.
4
Comparison of the Greek Version of the Quick Mild Cognitive Impairment Screen and Montreal Cognitive Assessment in Older Adults.希腊版快速轻度认知障碍筛查量表与蒙特利尔认知评估量表在老年人中的比较。
Healthcare (Basel). 2022 May 13;10(5):906. doi: 10.3390/healthcare10050906.
5
Comparison of the Six Item Cognitive Impairment Test (6CIT) to Commonly-Used Short Cognitive Screening Instruments in a Memory Clinic Population.六项认知障碍测试(6CIT)与记忆门诊人群中常用的简短认知筛查工具的比较。
J Alzheimers Dis Rep. 2023 Apr 20;7(1):299-306. doi: 10.3233/ADR220117. eCollection 2023.
6
Screening for Cognitive Impairment After Stroke: Validation of the Chinese Version of the Quick Mild Cognitive Impairment Screen.中风后认知障碍的筛查:中文版快速轻度认知障碍筛查量表的效度验证
Front Neurol. 2021 Mar 5;12:608188. doi: 10.3389/fneur.2021.608188. eCollection 2021.
7
Screening for Cognitive Frailty Using Short Cognitive Screening Instruments: Comparison of the Chinese Versions of the MoCA and Q Screen.使用简短认知筛查工具筛查认知衰弱:蒙特利尔认知评估量表(MoCA)和Q筛查量表中文版的比较
Front Psychol. 2020 Apr 3;11:558. doi: 10.3389/fpsyg.2020.00558. eCollection 2020.
8
Screening for Cognitive Impairment with the Quick Memory Check: Validation of a Caregiver Administered Cognitive Screen.使用快速记忆检查筛查认知障碍:一项由照料者实施的认知筛查的验证
J Alzheimers Dis. 2022;90(4):1417-1427. doi: 10.3233/JAD-220339.
9
The Persian Version of the Quick Mild Cognitive Impairment Screen (Q-Pr): Psychometric Properties among Middle-Aged and Older Iranian Adults.《快速轻度认知障碍筛查简易中文版(Q-Pr)》在伊朗中老年人群中的心理测量学特征。
Int J Environ Res Public Health. 2021 Aug 14;18(16):8582. doi: 10.3390/ijerph18168582.
10
Comparing the Diagnostic Accuracy of Two Cognitive Screening Instruments in Different Dementia Subtypes and Clinical Depression.比较两种认知筛查工具在不同痴呆亚型和临床抑郁症中的诊断准确性。
Diagnostics (Basel). 2019 Aug 8;9(3):93. doi: 10.3390/diagnostics9030093.

本文引用的文献

1
Floor and ceiling effects on the Montreal Cognitive Assessment in patients with Parkinson's disease in Brazil.巴西帕金森病患者蒙特利尔认知评估中的地板效应和天花板效应。
Dement Neuropsychol. 2023 Dec 4;17:e20230022. doi: 10.1590/1980-5764-DN-2023-0022. eCollection 2023.
2
Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis.哪种测试最适合评估帕金森病伴轻度认知障碍和痴呆患者的视觉认知障碍?一项系统评价和荟萃分析。
J Parkinsons Dis. 2022;12(6):1749-1782. doi: 10.3233/JPD-223238.
3
Epidemiology and economic burden of Lewy body dementia in the United States.
美国路易体痴呆的流行病学和经济负担。
Curr Med Res Opin. 2022 Jul;38(7):1177-1188. doi: 10.1080/03007995.2022.2059978. Epub 2022 Apr 20.
4
Global Trends in the Incidence, Prevalence, and Years Lived With Disability of Parkinson's Disease in 204 Countries/Territories From 1990 to 2019.2019 年全球 204 个国家和地区帕金森病发病率、患病率和伤残调整生命年的变化趋势
Front Public Health. 2021 Dec 7;9:776847. doi: 10.3389/fpubh.2021.776847. eCollection 2021.
5
Montreal Cognitive Assessment for the detection of dementia.蒙特利尔认知评估用于痴呆的检测。
Cochrane Database Syst Rev. 2021 Jul 13;7(7):CD010775. doi: 10.1002/14651858.CD010775.pub3.
6
The Cognitive Profile of Mild Cognitive Impairment Due to Dementia With Lewy Bodies-An Updated Review.路易体痴呆所致轻度认知障碍的认知特征——最新综述
Front Aging Neurosci. 2020 Dec 23;12:597579. doi: 10.3389/fnagi.2020.597579. eCollection 2020.
7
Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review.用于评估帕金森病认知障碍的帕金森病认知评定量表:一项系统评价
Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588.
8
The Montreal Cognitive Assessment: Is It Suitable for Identifying Mild Cognitive Impairment in Parkinson's Disease?蒙特利尔认知评估量表:它适用于识别帕金森病中的轻度认知障碍吗?
Mov Disord Clin Pract. 2020 Jun 25;7(6):648-655. doi: 10.1002/mdc3.12969. eCollection 2020 Aug.
9
Anticholinergic Drugs in Geriatric Psychopharmacology.老年精神药理学中的抗胆碱能药物
Front Neurosci. 2019 Dec 6;13:1309. doi: 10.3389/fnins.2019.01309. eCollection 2019.
10
Cut-off points of the Portuguese version of the Montreal Cognitive Assessment for cognitive evaluation in Parkinson's disease.帕金森病认知评估中蒙特利尔认知评估葡萄牙语版本的截断点。
Dement Neuropsychol. 2019 Apr-Jun;13(2):210-215. doi: 10.1590/1980-57642018dn13-020010.